TrialClinical and translational science2025

Evaluating miRNA Sequencing and Integrative Proteomics for Identifying Plasma miRNAs as Potential Pharmacodynamic Biomarkers of IFNβ-1a Biologics.

Mai Mehanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.